The relationship between virus load response to highly active antiretroviral therapy and change in CD4 cell counts: A report from the Women's Interagency HIV Study

Journal of Infectious Diseases

Volumn 182, Issue 5, 2000, Pages 1527-1530

  DeHovitz, Jack A ^a   Kovacs, Andrea ^b   Feldman, Joseph G ^a   Anastos, Kathryn ^c   Young, Mary ^d   Cohen, Mardge ^e   Gange, Stephen J ^f   Melnick, Sandra ^g   Greenblatt, Ruth M ^h  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c Catholic Medical Centers of New York   (United States)

^d GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Jr Hospital of Cook County   (United States)

^f JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^g NATIONAL CANCER INSTITUTE   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; VIRUS RNA;

ADULT; ANTIVIRAL ACTIVITY; ARTICLE; DRUG RESPONSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; FEMALE; HIV-1; HUMAN; MIDDLE AGE; RNA, VIRAL; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0033788216     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315875     Document Type: Article

References (15)

1. Treatment of indinavir, zidovudine, and lamivudine with human immunodeficiency virus infection and prior antiretroviral therapy
2. Simultaneous vs. sequential initiation of therapy with indinavir, zidovudine and lamivudine for HIV-1 infection: 100 Week follow-up
3. Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults
4. HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: Response to both initial and salvage therapy
5. Highly active antiretroviral therapy in a large urban clinic: Risk factors for virologic failure and adverse drug reactions
6. Effectiveness of highly active antiretroviral therapy among HIV-1 infected women
7. Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: A prospective cohort study
8. CD4-cell count in HIV-1 infected individuals remaining viraemic with highly active antiretroviral therapy (HAART)
9. The Women's Interagency HIV Study (WIHS): Design, methods, sample, cohort characteristics and comparison with reported AIDS cases in U.S. women
10. + T cell response after virologic failure of protease inhibitor-based regimens in patients with human immunodeficiency virus infection
11. Lack of fitness of protease inhibitor-resistant HIV-1 in vivo
12. Replicative fitness of protease inhibitor-resistant mutants of human immunodeficiency virus type 1
13. Antiviral therapy may preferentially eliminate CXCR4-specific strains of HIV-1
14. The effect of virologic control on rates of disease progression: Finding from the CHORUS cohort